PRAXIS PRECISION MEDICINES I (PRAX) Stock Analyst Ratings
NASDAQ:PRAX • US74006W2070
335.28 USD
+3.67 (+1.11%)
At close: Feb 20, 2026
335.28 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM
ChartMill assigns a Buy % Consensus number of 83% to PRAX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 597.99. This target is 78.36% above the current price.
- PRAX was analyzed by 21 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PRAX.
- In the previous month the buy percentage consensus was at a similar level.
- PRAX was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-20 | Wedbush | Maintains | Underperform -> Underperform |
| 2026-02-20 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-20 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-20 | Baird | Maintains | Outperform -> Outperform |
| 2026-02-10 | Guggenheim | Maintains | Buy -> Buy |
| 2026-02-04 | Needham | Maintains | Buy -> Buy |
| 2026-02-02 | Wells Fargo | Initiate | Equal-Weight |
| 2026-01-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-12 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-12-29 | BTIG | Maintains | Buy -> Buy |
| 2025-12-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-09 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-09 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-08 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-08 | BTIG | Maintains | Buy -> Buy |
| 2025-12-08 | Needham | Maintains | Buy -> Buy |
| 2025-12-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-05 | Needham | Maintains | Buy -> Buy |
| 2025-12-05 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-12-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-01 | Needham | Reiterate | Buy -> Buy |
| 2025-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-19 | BTIG | Initiate | Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-06 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-10-20 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-10-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-17 | Guggenheim | Maintains | Buy -> Buy |
PRAXIS PRECISION MEDICINES I / PRAX FAQ
What is the price target for PRAX stock?
21 analysts have analysed PRAX and the average price target is 597.99 USD. This implies a price increase of 78.36% is expected in the next year compared to the current price of 335.28.
What is the consensus rating for PRAXIS PRECISION MEDICINES I (PRAX) stock?
The consensus rating for PRAXIS PRECISION MEDICINES I (PRAX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for PRAX stock?
The number of analysts covering PRAXIS PRECISION MEDICINES I (PRAX) is 21.